Twist Bioscience Corp (TWST)
42.23
+0.57
(+1.37%)
USD |
NASDAQ |
Nov 22, 16:00
42.26
+0.03
(+0.07%)
After-Hours: 20:00
Twist Bioscience Cash from Operations (Quarterly): -15.32M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -15.32M |
June 30, 2024 | -6.378M |
March 31, 2024 | -19.42M |
December 31, 2023 | -22.97M |
September 30, 2023 | -20.70M |
June 30, 2023 | -23.41M |
March 31, 2023 | -44.29M |
December 31, 2022 | -54.07M |
September 30, 2022 | -1.267M |
June 30, 2022 | -34.12M |
March 31, 2022 | -42.34M |
December 31, 2021 | -46.65M |
September 30, 2021 | -34.80M |
June 30, 2021 | -27.96M |
Date | Value |
---|---|
March 31, 2021 | -24.55M |
December 31, 2020 | -24.93M |
September 30, 2020 | -25.20M |
June 30, 2020 | -23.47M |
March 31, 2020 | -58.67M |
December 31, 2019 | -34.91M |
September 30, 2019 | -23.36M |
June 30, 2019 | -22.08M |
March 31, 2019 | -20.81M |
December 31, 2018 | -21.68M |
September 30, 2018 | -16.70M |
June 30, 2018 | -16.94M |
March 31, 2018 | -16.51M |
December 31, 2017 | -16.02M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-58.67M
Minimum
Mar 2020
-1.267M
Maximum
Sep 2022
-29.27M
Average
-25.07M
Median
Cash from Operations (Quarterly) Benchmarks
Microbot Medical Inc | -2.759M |
Perspective Therapeutics Inc | 3.366M |
Retractable Technologies Inc | -5.727M |
Xtant Medical Holdings Inc | -1.718M |
Catheter Precision Inc | -2.768M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -1.285M |
Cash from Financing (Quarterly) | 3.627M |
Free Cash Flow | -69.17M |
Free Cash Flow Per Share (Quarterly) | -0.2954 |
Free Cash Flow to Equity (Quarterly) | -17.32M |
Free Cash Flow to Firm (Quarterly) | -17.32M |
Free Cash Flow Yield | -2.82% |